Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase IV Inhibitors”

167 trials

Showing 20 of 167 results

Post-approval studies (Phase 4)Study completedNCT03819127
What this trial is testing

Vildagliptin in Older Adults With Diabetes and Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
University of Catania 60
Post-approval studies (Phase 4)Study completedNCT02442817
What this trial is testing

Linagliptin and Mesenchymal Stem Cells: A Pilot Study

Who this might be right for
Schizophrenia
University of Nevada, Reno 10
Large-scale testing (Phase 3)Ended earlyNCT00998686
What this trial is testing

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Phenomix 650
Large-scale testing (Phase 3)Ended earlyNCT00850239
What this trial is testing

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Phenomix 700
Large-scale testing (Phase 3)Study completedNCT02314637
What this trial is testing

Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 240
Not applicableUnknownNCT05817097
What this trial is testing

Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database

Who this might be right for
Cerebral InfarctionInfarction, BrainDipeptidyl-Peptidase IV Inhibitors
Ajou University School of Medicine 22,119
Not applicableEnded earlyNCT02244164
What this trial is testing

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Who this might be right for
Type 2 DiabetesIncretinomimeticsPancreas
Erasme University Hospital 5
Post-approval studies (Phase 4)UnknownNCT02528019
What this trial is testing

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Who this might be right for
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Kurume University 100
Early research (Phase 1)Study completedNCT05266404
What this trial is testing

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Who this might be right for
Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
AstraZeneca 46
Post-approval studies (Phase 4)UnknownNCT01660386
What this trial is testing

Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"

Who this might be right for
Type 2 Diabetes
Shanghai Jiao Tong University School of Medicine 12
Post-approval studies (Phase 4)Study completedNCT03178591
What this trial is testing

Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor

Who this might be right for
Diabetes Mellitus, Type 2Ischemic Heart Disease
Chiang Mai University 43
Large-scale testing (Phase 3)Not Yet RecruitingNCT07241897
What this trial is testing

DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes

Who this might be right for
Ischemic StrokeDiabete Mellitus
Second Affiliated Hospital of Soochow University 312
Not applicableStudy completedNCT03817463
What this trial is testing

Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 327,624
Not applicableStudy completedNCT04735042
What this trial is testing

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.

Who this might be right for
Type 2 DiabetesUrinary Tract Infections
University of Pisa 60
Not applicableStudy completedNCT02312375
What this trial is testing

Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients

Who this might be right for
Diabetes MellitusHypertension
Seoul National University Hospital 46
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Testing effectiveness (Phase 2)UnknownNCT04419337
What this trial is testing

Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

Who this might be right for
Diabetes MellitusStroke
Chang Gung Memorial Hospital 200
Large-scale testing (Phase 3)Study completedNCT02022007
What this trial is testing

Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis

Who this might be right for
Polycystic Ovary SyndromeDisorder of Glucose Regulation
Woman's 38
Not applicableStudy completedNCT00881543
What this trial is testing

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Who this might be right for
Diabetes Type 2
University of Sao Paulo General Hospital 45
Large-scale testing (Phase 3)WithdrawnNCT01038648
What this trial is testing

Sitagliptin in Prevention of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation